(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPTI-OX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OPTI-OX

ST13

US500000079293252

Class

1, 5, 9, 29, 40, 42

Filing

79293252

Registration

6391962

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

06/23/2026

Trademark type

Word

Nice classes

1, 5, 9, 29, 40, 42

Filing date

07/09/2020

Registration date

06/22/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/22/2021

Last transaction

06/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

GB

Examiner

RUTLAND, BARBARA A

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Bit Bio Limited

Representatives

Katrina G. Hull Markery Law, LLC

Technical classification

Nice Classes

Class 1Class 5Class 9Class 29Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use; chemical reagents for use in biotechnologyother than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use

Class 5

Pharmaceuticals in the nature of cell therapeutics for medicaltherapeutic or clinical use; genetically or otherwise modified cells for medical or clinical use; cells which are propagatedcultivated and expanded in bioreactors for medical or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use in drug screening; cell preparations for genetic testing and screening for clinical and medical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cellstissue culture mediacytokinesantibodies and reagents for medical and diagnostic or clinical use; tissue culture media growth factors in the nature of cell growthcell growth media and nutritional supplements for in vitro culturingdevelopmentmaintenanceexpansionassay or manipulation of cells all for medical and clinical use; cell separation reagents for medical and clinical use; dietary supplements; protein supplements; nutrition supplements

Class 9

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medicalclinicalresearch and biomanufacturing purposesdownloadable and recorded software for conducting medical and clinical research and control laboratory biomanufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; laboratory apparatus for magnetic cell separationapparatus for the separation of cell populations for medical or clinical use; all the aforesaid goods excluding use for non-medical oxygen measurement

Class 29

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fishnot live

Class 40

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposesstem cells for scientific purposesstem cells other than for medical or veterinary purposesskeletal myocytes for research purposescortical neurons for research purposesbiological tissue for research and scientific purposesbiological tissue cultures other than for medical or veterinary purposescultures of cell media other than for medical or veterinary usechemical reagents for use in biotechnologyother than for medical or veterinary usenutritive agents for processing living cells other than for medical usesemi-processed natural proteins for manufacturing foodproteins for use in the manufacture of food productsproteins for use in recombinant dna technology other than for medical usecell therapeuticsgenetically or otherwise modified cellscells which are propagatedcultivated and expanded in bioreactorscells for the purpose of tissue regenerationliving cells for medical usecells for medical usebiological preparations for medical usediagnostic preparations for medical and/or veterinary purposescell preparations for drug screeningcell preparations for genetic testingscreeningstem cells for medical purposesstem cells for veterinary purposescell growth mediatissue culture mediacytokinesantibodiesreagents for medicalmedical research or diagnostic usetissue culture mediagrowth factorsgrowth mediaserumnutritional supplements for in vitro culturingdevelopmentmaintenanceexpansionassay or manipulation of cellscell separation reagentsmagnetic cell separation equipmentdietary supplementsprotein supplementsnutrition supplementsmeatmeat substitutestissue engineered meatsynthetic meatcultured meatlaboratory-grown meat and fishnot live

Class 42

Biotechnology research; scientific testing for others in the area of biotechnology for researchclinicaltherapeutic and manufacturing purposes; stem cell research; synthetic biology servicesnamely biological research; stem cell biology servicesbiological research; scientific services for researchclinicaltherapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testingscreening; research and development in relation to drug screening; cell separation technology servicesresearch of technology in the field of cell separation; cell separation research services; consultancy relating to biotechnology; scientific and research consultancy relating to drug screening for forensic research purposes; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discoverycell therapystem cellsmicroorganismshuman tissuessynthetic biology and manufacturing; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; development and testing of computing methodssoftware algorithms and software for medicalclinicalresearch and biomanufacturing purposes

Publications

History of USPTO decisions and trademark events.

31 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/22/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/08/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/14/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/08/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/04/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/04/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/13/2021

FIMP

FINAL DISPOSITION PROCESSED

10/13/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/22/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

06/22/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/06/2021

PUBO

PUBLISHED FOR OPPOSITION

04/06/2021

GPNX

NOTIFICATION PROCESSED BY IB

04/05/2021

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

03/18/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/17/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/17/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/17/2021

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

02/28/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/27/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/26/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/26/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/26/2021

RFNT

REFUSAL PROCESSED BY IB

11/09/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/16/2020

RFRR

REFUSAL PROCESSED BY MPU

10/16/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/24/2020

CNRT

NON-FINAL ACTION WRITTEN

09/23/2020

DOCK

ASSIGNED TO EXAMINER

09/18/2020

MAFR

APPLICATION FILING RECEIPT MAILED

09/15/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/11/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/10/2020

Continuous trademark protection

Get notified about every new filing that threatens OPTI-OX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.